FDA Memo Blasts Diabetes Medicine Avandia
Sens. Charles Grassley, I-Iowa, and Max Baucus, D-Mont., have released an October 2008 memo written by FDA drug-safety reviewers Drs. David Graham and Kate Gelperin. The memo concludes that Avandia poses serious risks exceeding those of Actos, a competing drug.